ADAMIS PHARMACEUTICALS CORP (ADMP) Forecast, Price Target & Analyst Ratings
NASDAQ:ADMP • US00547W3079
0.7751 USD
+0.01 (+0.86%)
At close: Sep 7, 2023
0.77 USD
-0.01 (-0.66%)
After Hours: 9/7/2023, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADAMIS PHARMACEUTICALS CORP (ADMP).
Forecast Snapshot
Consensus Price Target
$0.43
-44.73% Downside
Next Earnings Forecast
Release DateNov 13, 2023
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.43
Upside
-44.73%
From current price of $0.78 to mean target of $0.43, Based on 6 analyst forecasts
Low
$0.42
Median
$0.43
High
$0.44
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ADMP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ADMP.
In the previous month the buy percentage consensus was at a similar level.
ADMP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 13, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.78M -87.43% | 2.21M -20.50% | 4.76M 115.38% | |
| EBITDA YoY % growth | -28.07M -7.59% | -30.63M -9.12% | -23.58M 23.02% | |
| EBIT YoY % growth | -31.68M -9.13% | -32.07M -1.23% | -25.06M 21.86% | |
| Operating Margin | -1,139.57% | -1,451.13% | -526.47% | |
| EPS YoY % growth | -0.62 -12.73% | -0.35 43.55% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ADAMIS PHARMACEUTICALS CORP / ADMP Forecast FAQ
What is the price target for ADMP stock?
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751.
Can you provide the upcoming earnings date for ADAMIS PHARMACEUTICALS CORP?
ADAMIS PHARMACEUTICALS CORP (ADMP) will report earnings on 2023-11-13, after the market close.